The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Blood Urea Nitrogen

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Blood Urea Nitrogen


Psychiatry related information on Blood Urea Nitrogen


High impact information on Blood Urea Nitrogen

  • The adequacy of dialysis was assessed by measuring the percent reduction in the blood urea nitrogen concentration and the serum albumin concentration [9].
  • Even though creatinine clearance decreased significantly (P = 0.001), control of blood urea nitrogen and serum creatinine was adequate [10].
  • We observed elevation of serum creatinine and blood urea nitrogen and decrease in creatine clearance in patients taking anti-inflammatory doses of aspirin [11].
  • Serum analysis in the same mice showed no elevation in blood urea nitrogen, indicating lack of effect on kidney function but a statistically significant (P =.046), albeit non-life-threatening, elevation in liver alanine aminotransferase levels [12].
  • Early administration of Roscovitine reduced immunostaining for collagen type IV, laminin, and fibronectin at days 5 and 10 (r = 0.984; P < 0.001), which was associated with improved renal function (urinary protein/creatinine, blood urea nitrogen, P < 0.05) [13].

Chemical compound and disease context of Blood Urea Nitrogen


Biological context of Blood Urea Nitrogen


Anatomical context of Blood Urea Nitrogen


Associations of Blood Urea Nitrogen with chemical compounds


Gene context of Blood Urea Nitrogen


Analytical, diagnostic and therapeutic context of Blood Urea Nitrogen


  1. Clinical and laboratory manifestations of toxic shock syndrome. Tofte, R.W., Williams, D.N. Ann. Intern. Med. (1982) [Pubmed]
  2. Spurious serum creatinine elevations in ketoacidosis. Molitch, M.E., Rodman, E., Hirsch, C.A., Dubinsky, E. Ann. Intern. Med. (1980) [Pubmed]
  3. Cyclosporine therapy for advanced Langerhans cell histiocytosis. Mahmoud, H.H., Wang, W.C., Murphy, S.B. Blood (1991) [Pubmed]
  4. Hepatorenal syndrome without avid sodium retention. Dudley, F.J., Kanel, G.C., Wood, L.J., Reynolds, T.B. Hepatology (1986) [Pubmed]
  5. Parabiotic transfer of cancer anorexia/cachexia in male rats. Norton, J.A., Moley, J.F., Green, M.V., Carson, R.E., Morrison, S.D. Cancer Res. (1985) [Pubmed]
  6. Recurrent de novo interstitial deletion of 16q in two mentally retarded sisters. Hoo, J.J., Lowry, R.B., Lin, C.C., Haslam, R.H. Clin. Genet. (1985) [Pubmed]
  7. Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival. Attali, P., Prod'Homme, S., Pelletier, G., Papoz, L., Ink, O., Buffet, C., Etienne, J.P. Cancer (1987) [Pubmed]
  8. Toxic irreversible encephalopathy induced by lithium carbonate and haloperidol. A report of 2 cases. Sandyk, R., Hurwitz, M.D. S. Afr. Med. J. (1983) [Pubmed]
  9. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. Ifudu, O., Feldman, J., Friedman, E.A. N. Engl. J. Med. (1996) [Pubmed]
  10. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease. Amair, P., Khanna, R., Leibel, B., Pierratos, A., Vas, S., Meema, E., Blair, G., Chisolm, L., Vas, M., Zingg, W., Digenis, G., Oreopoulos, D. N. Engl. J. Med. (1982) [Pubmed]
  11. Aspirin-induced depression of renal function. Kimberly, R.P., Plotz, P.H. N. Engl. J. Med. (1977) [Pubmed]
  12. Targeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTAT. Vallera, D.A., Li, C., Jin, N., Panoskaltsis-Mortari, A., Hall, W.A. J. Natl. Cancer Inst. (2002) [Pubmed]
  13. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist. Pippin, J.W., Qu, Q., Meijer, L., Shankland, S.J. J. Clin. Invest. (1997) [Pubmed]
  14. Effectiveness of steroid/antibiotic treatment in primates administered LD100 Escherichia coli. Hinshaw, L.B., Beller-Todd, B.K., Archer, L.T., Benjamin, B., Flournoy, D.J., Passey, R., Wilson, M.F. Ann. Surg. (1981) [Pubmed]
  15. Factors affecting immediate and long-term survival after emergent and elective splanchnic-systemic shunts. Chandler, J.G., Van Meter, C.H., Kaiser, D.L., Mills, S.E. Ann. Surg. (1985) [Pubmed]
  16. Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia. Singhal, P.C., Kumar, A., Desroches, L., Gibbons, N., Mattana, J. Am. J. Med. (1992) [Pubmed]
  17. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion. Park, P., Haas, M., Cunningham, P.N., Alexander, J.J., Bao, L., Guthridge, J.M., Kraus, D.M., Holers, V.M., Quigg, R.J. J. Am. Soc. Nephrol. (2001) [Pubmed]
  18. The influence of androgen deprivation therapy on metabolism in patients with prostate cancer. Nishiyama, T., Ishizaki, F., Anraku, T., Shimura, H., Takahashi, K. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  19. Complications of diuresis in the alcoholic patient with ascites: a controlled trial. Gregory, P.B., Broekelschen, P.H., Hill, M.D., Lipton, A.B., Knauer, C.M., Egger, M., Miller, R. Gastroenterology (1977) [Pubmed]
  20. Predicting death in patients hospitalized for community-acquired pneumonia. Farr, B.M., Sloman, A.J., Fisch, M.J. Ann. Intern. Med. (1991) [Pubmed]
  21. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Alappan, R., Perazella, M.A., Buller, G.K. Ann. Intern. Med. (1996) [Pubmed]
  22. Genetic deletion of murine SPRY domain-containing SOCS box protein 2 (SSB-2) results in very mild thrombocytopenia. Masters, S.L., Palmer, K.R., Stevenson, W.S., Metcalf, D., Viney, E.M., Sprigg, N.S., Alexander, W.S., Nicola, N.A., Nicholson, S.E. Mol. Cell. Biol. (2005) [Pubmed]
  23. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. Laffi, G., Marra, F., Buzzelli, G., Azzena, G., Meacci, E., De Feo, M.L., La Villa, G., Gentilini, P. Hepatology (1991) [Pubmed]
  24. Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension. Guazzi, M.D., De Cesare, N., Galli, C., Salvioni, A., Tramontana, C., Tamborini, G., Bartorelli, A. Circulation (1984) [Pubmed]
  25. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats. Ohno, S., Strebel, F.R., Stephens, L.C., Siddik, Z.H., Makino, M., Klostergaard, J., Tomasovic, S.P., Khokhar, A.R., Bull, J.M. Cancer Res. (1992) [Pubmed]
  26. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. Wu, A.H., Aaronson, K.D., Bolling, S.F., Pagani, F.D., Welch, K., Koelling, T.M. J. Am. Coll. Cardiol. (2005) [Pubmed]
  27. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. Anders, H.J., Belemezova, E., Eis, V., Segerer, S., Vielhauer, V., Perez de Lema, G., Kretzler, M., Cohen, C.D., Frink, M., Horuk, R., Hudkins, K.L., Alpers, C.E., Mampaso, F., Schlöndorff, D. J. Am. Soc. Nephrol. (2004) [Pubmed]
  28. Dietary intake and biochemical, hematologic, and immune status of vegans compared with nonvegetarians. Haddad, E.H., Berk, L.S., Kettering, J.D., Hubbard, R.W., Peters, W.R. Am. J. Clin. Nutr. (1999) [Pubmed]
  29. Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity. Humes, H.D., Sastrasinh, M., Weinberg, J.M. J. Clin. Invest. (1984) [Pubmed]
  30. Biosynthetic methionyl human growth hormones is biologically active in adult man. Hintz, R.L., Rosenfeld, R.G., Wilson, D.M., Bennett, A., Finno, J., McClellan, B., Swift, R. Lancet (1982) [Pubmed]
  31. Renal failure associated with demeclocycline in cirrhosis. Carrilho, F., Bosch, J., Arroyo, V., Mas, A., Viver, J., Rodes, J. Ann. Intern. Med. (1977) [Pubmed]
  32. Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model. Borch, R.F., Pleasants, M.E. Proc. Natl. Acad. Sci. U.S.A. (1979) [Pubmed]
  33. Tyrphostin 4-nitrobenzylidene malononitrile reduces chemotherapy toxicity without impairing efficacy. Novogrodsky, A., Weisspapir, M., Patya, M., Meshorer, A., Vanichkin, A. Cancer Res. (1998) [Pubmed]
  34. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Maldonado, P.D., Barrera, D., Rivero, I., Mata, R., Medina-Campos, O.N., Hernández-Pando, R., Pedraza-Chaverrí, J. Free Radic. Biol. Med. (2003) [Pubmed]
  35. Liver and kidney function in Japanese patients with maturity-onset diabetes of the young. Iwasaki, N., Ogata, M., Tomonaga, O., Kuroki, H., Kasahara, T., Yano, N., Iwamoto, Y. Diabetes Care (1998) [Pubmed]
  36. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Zhang, J.J., Bledsoe, G., Kato, K., Chao, L., Chao, J. Kidney Int. (2004) [Pubmed]
  37. Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis. Faubel, S., Ljubanovic, D., Reznikov, L., Somerset, H., Dinarello, C.A., Edelstein, C.L. Kidney Int. (2004) [Pubmed]
  38. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Ramesh, G., Reeves, W.B. Am. J. Physiol. Renal Physiol. (2005) [Pubmed]
  39. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Kawaida, K., Matsumoto, K., Shimazu, H., Nakamura, T. Proc. Natl. Acad. Sci. U.S.A. (1994) [Pubmed]
  40. Acute, chronic and terminal toxicity to 4'-demethylepipodophyllotoxin thenylidene glucoside (VM26) in mice. Hacker, M., Roberts, D.W. Cancer Res. (1975) [Pubmed]
  41. Benign azotemia of long-term hemodialysis: increase in blood urea nitrogen and serum creatinine concentrations after the initiation of dialysis. Abuelo, J.G. Am. J. Med. (1989) [Pubmed]
  42. Heroin-associated rhabdomyolysis with cardiac involvement. Schwartzfarb, L., Singh, G., Marcus, D. Arch. Intern. Med. (1977) [Pubmed]
  43. Acute renal failure following blunt civilian trauma. Matas, A.J., Payne, W.D., Simmons, R.L., Buselmeier, T.J., Kjellstrand, C.M. Ann. Surg. (1977) [Pubmed]
WikiGenes - Universities